Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
Patients with inflammatory bowel disease (IBD) have an increased risk of colon cancer. However, the immune cells and cytokines that mediate the transition from intestinal inflammation to cancer are poorly understood. We show that bacteria-induced colon cancer is accompanied by differential accumulation of IL-17(+)IL-22(+) colonic innate lymphoid cells (cILCs), which are phenotypically distinct from LTi and NK-22 cells, and that their depletion in mice with dysplastic inflammation blocks the development of invasive colon cancer. Analysis of the functional role of distinct Type 17 cytokines shows that although blockade of IL-17 inhibits some parameters of intestinal inflammation, reduction in dysplasia and colorectal cancer (CRC) requires neutralization of IL-22 indicating a unique role for IL-22 in the maintenance of cancer in this model. Mechanistic analyses showed that IL-22 selectively acts on epithelial cells to induce Stat3 phosphorylation and proliferation. Importantly, we could detect IL-22(+)CD3(+) and IL-22(+)CD3(−) cells in human CRC. Our results describe a new activity of IL-22 in the colon as a nonredundant mediator of the inflammatory cascade required for perpetuation of CRC, highlighting the IL-22 axis as a novel therapeutic target in colon cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although known to exert a tumor-promoting effect in colorectal cancer (Kirchberger et al., 2013; Wang et al., 2017)”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Kirchberger et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039 · cited 1×
“…in many mouse models (Hue et al., 2006; Izcue et al., 2008), and its components IL-23R and Stat3 are not only associated with IBD susceptibility (Duerr et al., 2006; Barrett et al., 2008) but also involved in inflammation-associated cancer in the skin and colon (Langowski et al., 2006; Bollrath…”
BackgroundThe risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 1×
“In inflammatory bowel disease (IBD) patients, deranged inflammatory responses toward the intestinal microbiota increase the risk of colon cancer twofold (Eaden et al., 2001).”
BackgroundGenome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593 · cited 1×
“…(Hue et al., 2006; Izcue et al., 2008), and its components IL-23R and Stat3 are not only associated with IBD susceptibility (Duerr et al., 2006; Barrett et al., 2008) but also involved in inflammation-associated cancer in the skin and colon (Langowski et al., 2006; Bollrath et al., 2009;…”
BackgroundLiang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 8×
“It is now appreciated that a Type 17 cytokine expression signature is not restricted to Th-17 cells, and that cytokines such as IL-17 and IL-22 can be produced by unconventional T cell populations and more recently described RORtexpressing innate lymphoid populations (Pearson et al., 2012).”
BackgroundInfluentialCrypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166 · cited 1×
“IL-22 may also promote cancer through direct effects on intestinal epithelial stem cells, previously shown to be key precursors for intestinal cancer (Barker et al., 2009).”
BackgroundGrivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155 · cited 2×
“The role of Stat3 in colon cancer is well known but this has been attributed to activation by IL-6 and IL-11 (Ernst et al., 2008; Grivennikov et al., 2009).”
BackgroundFusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043 · cited 1×
“Furthermore, certain species like the anaerobic Fusobacterium nucleatum were found to be associated with human CRC tissue (Castellarin et al., 2012; Kostic et al., 2012).”
BackgroundGenomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960 · cited 1×
“Furthermore, certain species like the anaerobic Fusobacterium nucleatum were found to be associated with human CRC tissue (Castellarin et al., 2012; Kostic et al., 2012).”
BackgroundInterleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., et al. (2008) · Nature Medicine · doi:10.1038/nm1720 · Cited by 1,921 · cited 8×
“IL-23 also drives colon cancer in an APC model, where it is induced in tumor-associated myeloid 928 Interleukin-22 in colon cancer | Kirchberger et al. (Reference numbers: 11/YH/0020 and 09/H0606/5) and informed written consent was given by all study patients.”
BackgroundInfluentialWu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812 · cited 3×
“Th17 cell infiltration was also found in animal models of colon cancer, such as the ApcMin model driven by the enterotoxigenic bacterium Bacteroides fragilis, where blockade of IL-17 decreased tumor incidence (Wu et al., 2009).”
Background
Cited by
Items 501–529 of 529
Circulating innate lymphoid cells and IL-18 as potential immune biomarkers in thymic tumors
Maresca, D. C., Saponaro, M. R., Civita, E. L., Tortora, M., Romano, B., Pietroluongo, E., Somma, F., Giuliano, M., Servetto, A., Palmieri, G., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1705648
Additional file 1 of Exploring immunotherapy in colorectal cancer
Weng, J., Li, S., Zhu, Z., Liu, Q., Zhang, R., Yang, Y., & Li, X. (2022) · Figshare · doi:10.6084/m9.figshare.20330034
Gao, J., Wei, J., Qin, S., Liu, S., Mo, S., Long, Q., Tan, S., Lu, N., Xie, Z., & Lin, J. (2024) · Figshare · doi:10.6084/m9.figshare.24355134
Gao, J., Wei, J., Qin, S., Liu, S., Mo, S., Long, Q., Tan, S., Lu, N., Xie, Z., & Lin, J. (2023) · Figshare · doi:10.6084/m9.figshare.24355014
Tissue-Specific Spatial Regulation of Innate Immune Checkpoints in Cancer
Stojanovic, A., Giorgetta, S., Vonhören, D., Krieghoff‐Henning, E., Platten, M., Loges, S., Tugues, S., & Cerwenka, A. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-2112
Trichuris suis ova in inflammatory bowel disease-clinical challenges and translational pathways
Zhou, S., Tang, J., & Wang, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1611690 · Cited by 2
“The accumulation of interleukin-17 and interleukin-22 coexpressing cells is associated with colorectal cancer (122).”
Role of the gut microbiome in the development of colorectal cancer
Shanbhag, A. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00040-6
Guillon, A. (2014) · theses.fr (ABES) · doi:10.70675/042b0391zd3cez4417zb829zd1ecdc552f84
Humanized Mice as Models to study Human Innate Immunity and Immunotherapies
Lopez‐Lastra, S. (2017) · theses.fr (ABES) · doi:10.70675/332ff2f4z793bz4a95zbffcz4be18383be48
Régulation du développement et de la fonction des cellules innées lymphoïdes NKp46+
Viant, C. (2016) · theses.fr (ABES) · doi:10.70675/3d6d7190z9e08z426fz9dfaz0bb48d4f7808
Erdem, Ş., Haliloğlu, Y., Uslu, İ. N., Houran, M. A., Ulutabanca, H., Vural, A., Erturhan, M. B., Canatan, H., & Eken, A. (2026) · Inflammation Research · doi:10.1007/s00011-026-02223-8
“Pro-tumor functions of ILC3s have been associated with IL-22-medi-ated support of tumor growth, epithelial proliferation, and chronic inflammation in models of colorectal, breast, hepatic, and cervical cancers [50– 56].”
CD28 : nouvelles données sur un récepteur majeur de la costimulation lymphocytaire T
Morin, S. O. (2017) · theses.fr (ABES) · doi:10.70675/cb01635fz2f63z43e2zad0cz210485c4c5cf
Rôles de l’autophagie dans l'homéostasie des cellules souches intestinales
Trentesaux, C. (2018) · theses.fr (ABES) · doi:10.70675/6bad110bz19b1z4cd6z81d0z74d0fb1e27f3
Transcriptional Control of NK and iNKT Cell Development
Zhang, J. (2020) · theses.fr (ABES) · doi:10.70675/073dcbf5z7332z40c0zbba4z555a9ace31a5
Caractérisation transcriptomique des cellules lymphoïdes innées
Crinier, A. (2020) · theses.fr (ABES) · doi:10.70675/850e38aazc227z4187z9c41z07c47cac00d9
An orthotopic syngeneic mouse model to study the role of DCIR in colorectal cancer
Trimaglio, G. (2020) · theses.fr (ABES) · doi:10.70675/f02ef1caz642dz435az890bz1ebbfbcec28b
Etude des mécanismes de régulation de l'activation des cellules natural killer
Guia, S. (2021) · theses.fr (ABES) · doi:10.70675/fe8a748dzb006z40a0z8e07z1043717cbdd0
Vermeulen, O. (2021) · theses.fr (ABES) · doi:10.70675/277aa48cz7ec5z4c99z9fe9z34e8ea73f6b5
Les cellules lymphoïdes dans la biologie et la pathologie musculaire
Saidj, T. (2022) · theses.fr (ABES) · doi:10.70675/8bd8c2daz45ffz4bcfzad71z3f11c2e9dead
Hou, Y., Wang, H., Li, J., Li, C., Sun, Y., Wang, Y., Zou, D., & Zhou, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1868875 · Cited by 2
“For example, IL-6, IL-1 β , TNF-α , IL-10, and nitric oxide (NO) promotes transition from chronic intestinal inflammation to cancer (Kirchberger et al., 2013; Brighenti et al., 2014 ).”
Innate lymphoid cells: Bridging basic biology and disease
Gelmez, M. Y., Öktelik, F. B., Kokoglu, A., Demir, S., Çınar, S., & Deniz, G. (2026) · Immunology Letters · doi:10.1016/j.imlet.2026.107226
Shen, Y., Chadwick, B. J., Peng, X., Gao, Y., & Ding, C. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2734644
Zinych, P. P., & Bolgov, М. Y. (2026) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.22.6.2026.1753
Xing, S., 张佳宇, Wang, S., Hao, Y., Huang, D., Hao, M., Bao, W., Qu, X., Chi, Y., & Li, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1923822
“For instance, IL-22 has been shown to promote the proliferation and inhibit the apoptosis of colorectal cancer cells by activating the STAT3 signaling pathway (117).”
Xu, S., Han, Q., Wang, F., Zhang, Y., Feng, H., Liu, K., Luo, F. X., Yuan, F., Zhao, X., Yu, X., et al. (2026) · Advanced Science · doi:10.1002/advs.78339
Metadata
- Authors
- Kirchberger, S., Royston, D. J., Boulard, O., Thornton, E., Franchini, F., Szabady, R. L., Harrison, O., & Powrie, F.
- Affiliations
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Corresponding author
- Powrie, Fiona
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-04-15
- Volume
- 210
- Issue
- 5
- Pages
- 917-931
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3646494
- OpenAlex
- W2124499950
- Cited by
- 529
- References
- 52
- Citations by year
- 2026: 18 · 2025: 12 · 2024: 24 · 2023: 33 · 2022: 39 · 2021: 34 · 2020: 54 · 2019: 51 · 2018: 42 · 2017: 55 · 2016: 48 · 2015: 54 · 2014: 50 · 2013: 12
- FWCI
- 30.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- Funders
- Royal College of Pathologists of Australasia
- Wellcome Trust (095688/Z/11/Z, 095688)
- Cancer Research UK (A7297, A11663)
- National Institute for Health and Care Research
- European Commission (223151)
- Jean Shanks Foundation
- Austrian Science Fund
- Genentech
- Biotechnology and Biological Sciences Research Council (BB/I005609/1)
- NIHR Oxford Biomedical Research Centre
- UCB Celltech
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- colon cancer, IL-22, IL-17, innate lymphoid cells, inflammatory bowel disease, STAT3 phosphorylation, epithelial cell proliferation, therapeutic target
- MeSH terms
- Interleukin-22, Animals, Antigens, Ly, Cell Transformation, Neoplastic, Colitis, Colon, Colonic Neoplasms, Disease Models, Animal, Epithelial Cells, Humans, Interleukins, Lymphocytes, Phosphorylation, CD4 Antigens, Gene Expression Regulation, Neoplastic, Helicobacter, Disease Progression, Cell Lineage, STAT3 Transcription Factor, Mice, Natural Cytotoxicity Triggering Receptor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.